SC 13G Filing

Company

AEON Biopharma, Inc.

Filed

March 10, 2023

Accession Number

0001076809-23-000185

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →